Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pott

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2016
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemiaM Ladetto, C Buske, M Hutchings, et al.
Oncogene|October 31, 2006
Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activityD T Starczynowski, H Trautmann, C Pott, et al.
British Journal of Pharmacology|October 22, 2011
Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failureP Milberg, M Fink, C Pott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2013
Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantationB Metzner, C Pott, T H Müller, et al.
Plos One|April 13, 2011
Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patientsJakob G Jespersen, Anders Nedergaard, Søren Reitelseder, et al.
Leukemia & Lymphoma|July 27, 2016
Polymerase Chain Reaction Analysis of t(14;18) Junctional Regions in B-Cell LymphomasM Kneba, S Eick, S Willigeroth, et al.
Leukemia|July 31, 2009
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysisS Böttcher, S Stilgenbauer, R Busch, et al.
Deutsche Medizinische Wochenschrift (1946)|October 25, 2002
[Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group]R Forstpointner, A Hänel, R Repp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-upM Kornacker, J Stumm, C Pott, et al.
Scientific Reports|February 26, 2021
Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolationF Cordes, C Ellermann, D G Dechering, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2016
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemiaM Ladetto, C Buske, M Hutchings, et al.
Oncogene|October 31, 2006
Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activityD T Starczynowski, H Trautmann, C Pott, et al.
British Journal of Pharmacology|October 22, 2011
Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failureP Milberg, M Fink, C Pott, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 9, 2013
Long-term clinical and molecular remissions in patients with follicular lymphoma following high-dose therapy and autologous stem cell transplantationB Metzner, C Pott, T H Müller, et al.
Plos One|April 13, 2011
Activated protein synthesis and suppressed protein breakdown signaling in skeletal muscle of critically ill patientsJakob G Jespersen, Anders Nedergaard, Søren Reitelseder, et al.
Leukemia & Lymphoma|July 27, 2016
Polymerase Chain Reaction Analysis of t(14;18) Junctional Regions in B-Cell LymphomasM Kneba, S Eick, S Willigeroth, et al.
Leukemia|July 31, 2009
Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysisS Böttcher, S Stilgenbauer, R Busch, et al.
Deutsche Medizinische Wochenschrift (1946)|October 25, 2002
[Increased response rate with rituximab in relapsed and refractory follicular and mantle cell lymphomas -- results of a prospective randomized study of the German Low-Grade Lymphoma Study Group]R Forstpointner, A Hänel, R Repp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-upM Kornacker, J Stumm, C Pott, et al.
Scientific Reports|February 26, 2021
Pre-procedural proton pump inhibition is associated with fewer peri-oesophageal lesions after cryoballoon pulmonary vein isolationF Cordes, C Ellermann, D G Dechering, et al.
Pageof 7